Nvidia Injects $50M into AI Drug Discovery Pioneer Recursion
08:42 Share

Dive into the latest collaboration as Nvidia pours a significant $50 million investment into Recursion, a trailblazing AI-driven drug discovery firm. Explore the potential synergies and groundbreaking advancements poised to reshape the landscape of pharmaceutical innovation.

Get on the AI Box Waitlist: https://AIBox.ai/)Join our ChatGPT Community: https://www.facebook.com/groups/739308654562189/)Follow me on Twitter: https://twitter.com/jaeden_ai)